WEBINAR: The Innovation Behind SkinPen Precision and Why It Matters to Your Practice

Recorded Date: 4/14/2020


 Crown Laboratories Chief Science Officer, Thomas Hitchcock, PhD will review the quality and design features of the 1st FDA-cleared microneedling device to market, SkinPen. To receive this FDA designation, SkinPen proactively worked through a rigorous three-year evaluation process to meet numerous validation requirements, many of which will be explained our part webinar series; including never before seen visual demonstrations.

Fill out the form on this page to get access to the webinar for free!

*Required. Your privacy matters to us.